UPMC Health Plan and Biogen Announce Groundbreaking Value-Based Agreement for Multiple Sclerosis Treatments
November 14, 2019 10:43 ET
|
UPMC Health Plan
Pittsburgh, Nov. 14, 2019 (GLOBE NEWSWIRE) -- UPMC Health Plan announced today that it has entered into a value-based agreement with Biogen for Tecfidera® (dimethyl fumarate) and Avonex® (interferon...